L-shaped correlation between serum alpha-1-acid glycoprotein concentration and urinary albumin creatinine ratio in females: a cross-sectional survey

女性血清α1-酸性糖蛋白浓度与尿白蛋白肌酐比值呈L型相关性:一项横断面调查

阅读:1

Abstract

BACKGROUND: Alpha-1-acid glycoprotein (AGP) is a vital acute phase reactant that increases when glomerular filtration is impaired, making it a potential biomarker of kidney disease. The urine albumin-to-creatinine ratio (UACR) is a sensitive indicator of proteinuria and is frequently used to screen for kidney disease in its early stage. The aim of this study was to explore their correlation in order to advance our understanding of the mechanisms underlying kidney damage. METHODS: This study included 2579 female participants with serum AGP and UACR from the National Health and Nutrition Examination Survey (2015-2018). We divided all participants equally into three groups based on their serum AGP concentration. The univariate and multivariate regression models were for assessing the correlation between AGP and UACR. Subgroup analyses were then performed to explore the effect of each covariate on the correlation. Smoothing splines was utilized to explore their nonlinear correlation and identify thresholds within it. RESULTS: After adjusting for multivariate models, AGP was significantly and positively associated with UACR (p<0.0001). The study identified a specific cohort of non-Hispanic Black individuals under 20 years of age, characterized by a BMI below 25 kg/m² and a waist circumference of 80 cm or more. Within this cohort, those with hypertension and sleep disorders but without hypercholesterolemia or diabetes exhibited significantly higher UACR (p < 0.001). Furthermore, we discovered an L-shaped correlation between serum AGP concentration and UACR. Specifically, when the serum AGP concentration was less than 140 mg/dL, the UACR plateaued. CONCLUSIONS: This study is the first to address the correlation between serum AGP and UACR and found an L-shaped correlation with a threshold of 140 mg/dl. This could be a target for intervention to reduce the risk of kidney disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。